Subcutaneous Bortezomib Plus Melphalan and Prednisone (VMP) in Non-Transplant Eligible Newly Diagnosed Multiple Myeloma (MM) Patients: Spanish Experience
Identifiers
Identifiers
Date issued
2015Journal title
Clinical Lymphoma Myeloma & Leukemia
Type of content
Publicación de congreso